A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerabilit...
Gilead Sciences Inc. a research-based biopharmaceutical company that discovers, develops and commercializes innovative m...
Trianni, Inc. and MacroGenics, Inc. has announced that they have entered into a license agreement for The Trianni Mouse,...
A group of researchers from the University of Queensland, Australia has developed a new method that will enable quick an...
Singapore – Scientists from A*STAR’s Singapore Immunology Network (SIgN) and Singapore Bioimaging Consortium...
Eureka Therapeutics has announced publication in Cell Discovery validating its ARTEMIS antibody-TCR (AbTC...
Geneious Biologics, an enterprise software solution for companies engaged in screening of antibodies and antibody-like m...
Nanyang Technological University, Singapore (NTU Singapore) is pioneering the use of 3D-printed anatomical specimens for...
A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...
Singapore – Scientists led by Duke-NUS Medical School have designed mice that successfully emulate a severe form o...
A group of scientists from Rutgers University-New Brunswick Rutgers has created a tiny, biodegradable scaffold to transp...
A research team at Hong Kong Polytechnic University (PolyU) has designed a robotic arm to facilitate self-help and upper...
Singapore - Breakthrough research to culture human skin cells called keratinocytes to produce skin grafts has been publi...
Singapore – Lucence Diagnostics announced the launch of the world’s first molecular test to distinguish...
Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...
A group of researchers at the Korea Advanced Institute of Science and Technology (KAIST), South Korea, has found that hu...
Singapore - Proteona Pte. Ltd. has entered into an exclusive worldwide licensing agreement with the National University ...
JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and...
